JP2009143850A - Method of preparing pyrazolinone derivative - Google Patents

Method of preparing pyrazolinone derivative Download PDF

Info

Publication number
JP2009143850A
JP2009143850A JP2007323130A JP2007323130A JP2009143850A JP 2009143850 A JP2009143850 A JP 2009143850A JP 2007323130 A JP2007323130 A JP 2007323130A JP 2007323130 A JP2007323130 A JP 2007323130A JP 2009143850 A JP2009143850 A JP 2009143850A
Authority
JP
Japan
Prior art keywords
pyrazolinone
group
general formula
atom
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007323130A
Other languages
Japanese (ja)
Inventor
Chikashi Yonehara
史 米原
Takao Inoguchi
貴郎 猪口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP2007323130A priority Critical patent/JP2009143850A/en
Priority to CN2008801208809A priority patent/CN101896466A/en
Priority to PCT/JP2008/073140 priority patent/WO2009078475A1/en
Publication of JP2009143850A publication Critical patent/JP2009143850A/en
Priority to IL206085A priority patent/IL206085A0/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method of preparing a pyrazolinone derivative (1-[(2-propenylthio)carbonyl]-4-(2-methylphenyl)-5-amino-1H-pyrazole-3-one, for example). <P>SOLUTION: A pyrazolinone derivative is prepared by causing a pyrazolinone compound represented by formula (1) (3-amino-4-(2-methylphenyl)-pyrazoline-5-one, for example) to react with an acid halide represented by formula (2) (acrylchlorothioformate, for example) in the presence of an alkali in a mixed liquid of water and an organic solvent, subjecting the resulting reaction mixture to an oil/water separation treatment, neutralizing the separated water phase by adding an acid thereinto to cause the resulting pyrazolinone derivative to precipitate, and isolating the precipitate. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、一般式(1)

Figure 2009143850
(式中、R1、R2、R3、R4及びR5はそれぞれ水素原子、ハロゲン原子又はハロゲン原子で置換されていてもよいメチル基を表す。R6は水素原子又は炭素数1〜5のアルキル基を表す。)
で示される化合物〔以下、ピラゾリノン化合物(1)ということがある。〕と、一般式(2)
Figure 2009143850
(式中、Xは塩素原子又は臭素原子を表し、Yは酸素原子又は硫黄原子を表す。R7は炭素数1〜5のアルキル基、炭素数3〜5のアルケニル基又は炭素数3〜5のアルキニル基を表す。)
で示される化合物〔以下、酸ハロゲン化物(2)ということがある。〕を塩基存在下で反応させ、一般式(3)
Figure 2009143850
(式中、R1、R2、R3、R4、R5、R6、R7及びYはそれぞれ前記と同じ意味を表す。)
で示される化合物〔以下、ピラゾリノン誘導体(3)ということがある。〕を製造する方法に関する。ピラゾリノン誘導体(3)は、例えば、農薬の原料として有用である。 The present invention relates to a general formula (1)
Figure 2009143850
(Wherein, R 1, R 2, R 3, R 4 and R 5 are each a hydrogen atom, .R 6 is 1 hydrogen atom or a carbon atoms of a halogen atom or a halogen atom which may be substituted methyl group 5 represents an alkyl group.)
[Hereinafter, it may be called a pyrazolinone compound (1). ] And general formula (2)
Figure 2009143850
(Wherein, X represents a chlorine atom or a bromine atom, Y is .R 7 is an alkyl group having 1 to 5 carbon atoms, 3-5 alkenyl group carbon atoms or 3 to 5 carbon atoms an oxygen atom or a sulfur atom Represents an alkynyl group of
[Hereinafter, referred to as acid halide (2). ] In the presence of a base to give a general formula (3)
Figure 2009143850
(Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and Y have the same meanings as described above).
[Hereinafter, it may be referred to as a pyrazolinone derivative (3). ] About the method of manufacturing. The pyrazolinone derivative (3) is useful as a raw material for agricultural chemicals, for example.

ピラゾリノン誘導体(3)の製造方法として、例えば特開2000−226374号公報(特許文献1)には、ピラゾリノン化合物(1)と酸ハロゲン化物(2)を水と疎水性有機溶媒との混合液中で塩基存在下に反応させ、得られた反応混合物を油水分離することなく酸処理し、溶媒抽出することにより、ピラゾリノン誘導体(3)を製造することが開示されている。 As a method for producing the pyrazolinone derivative (3), for example, Japanese Patent Application Laid-Open No. 2000-226374 (Patent Document 1) discloses that a pyrazolinone compound (1) and an acid halide (2) are mixed in water and a hydrophobic organic solvent. The reaction is carried out in the presence of a base, and the resulting reaction mixture is subjected to acid treatment without oil-water separation and solvent extraction to produce a pyrazolinone derivative (3).

特開2000−226374号公報JP 2000-226374 A

上記従来の方法では収率が必ずしも満足できるものではない。また反応の際には、目的物であるピラゾリノン誘導体(3)の他に、2分子のピラゾリノン化合物(1)がカルボニル基によって繋がった構造を持つ尿素化合物が副生するが、この副生物はピラゾリノン誘導体(3)の析出物中に取り込まれ易く、品質が低下し、ピラゾリノン誘導体(3)を使用する後工程にとって好ましくない。 In the above conventional method, the yield is not always satisfactory. In the reaction, in addition to the target pyrazolinone derivative (3), a urea compound having a structure in which two molecules of the pyrazolinone compound (1) are connected by a carbonyl group is produced as a by-product. It is easily taken into the precipitate of the derivative (3), the quality is lowered, and is not preferable for the post-process using the pyrazolinone derivative (3).

そこで、本発明の目的は、収率良く、上記副生物の取り込みを抑制して、良好な品質でピラゾリノン誘導体(3)を製造しうる方法を提供することにある。 Therefore, an object of the present invention is to provide a method capable of producing the pyrazolinone derivative (3) with good quality by suppressing the incorporation of the above-mentioned by-product with good yield.

本発明者らは鋭意研究を行った結果、ピラゾリノン化合物(1)と酸ハロゲン化物(2)を塩基存在下、水と疎水性有機溶媒との混合液中で反応させ、得られた反応混合物を油水分離し、水層に酸を加えて中和することによりピラゾリノン誘導体(3)を析出させ、分離することによって、収率が向上し、上記副生物の取り込みが抑制できることを見出し、本発明を完成するに至った。 As a result of intensive studies, the present inventors reacted the pyrazolinone compound (1) and the acid halide (2) in a mixed solution of water and a hydrophobic organic solvent in the presence of a base, and obtained the reaction mixture. The oil-water separation is carried out, and by adding an acid to the aqueous layer and neutralizing it, the pyrazolinone derivative (3) is precipitated and separated, and it is found that the yield can be improved and the incorporation of the by-product can be suppressed. It came to be completed.

すなわち本発明は、ピラゾリノン化合物(1)と酸ハロゲン化物(2)を塩基存在下、水と疎水性有機溶媒との混合液中で反応させ、得られた反応混合物を油水分離し、水層に酸を加えて中和し、ピラゾリノン誘導体(3)を析出させ、分離することを特徴とするピラゾリノン誘導体の製造方法を提供するものである。 That is, in the present invention, the pyrazolinone compound (1) and the acid halide (2) are reacted in a mixed solution of water and a hydrophobic organic solvent in the presence of a base, and the resulting reaction mixture is separated into oil and water to form an aqueous layer. The present invention provides a method for producing a pyrazolinone derivative characterized by adding an acid to neutralize to precipitate and separate the pyrazolinone derivative (3).

本発明によれば、収率良く、ピラゾリノン誘導体(3)を良好な品質で製造することができる。 According to the present invention, the pyrazolinone derivative (3) can be produced with good quality in good yield.

以下に本発明について詳細に説明する。ピラゾリノン化合物(1)を示す一般式(1)

Figure 2009143850
(式中、R1、R2、R3、R4及びR5はそれぞれ水素原子、ハロゲン原子又はハロゲン原子で置換されていてもよいメチル基を表す。R6は水素原子又は炭素数1〜5のアルキル基を表す。)
において、R1、R2、R3、R4及びR5の少なくとも1つがハロゲン原子又はハロゲン原子で置換されたメチル基である場合、このハロゲン原子は、フッ素原子、塩素原子、臭素原子又はヨウ素原子であることができる。また、ハロゲン原子で置換されたメチル基は、モノフルオロメチル基やモノクロロメチル基の如きモノハロメチル基であってもよいし、ジフルオロメチル基やジクロロメチル基の如きジハロメチル基であってもよいし、トリフルオロメチル基やトリクロロメチル基の如きトリハロメチル基であってもよい。R6が炭素数1〜5のアルキル基である場合、このアルキル基としては、例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、sec−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基等が挙げられる。 The present invention is described in detail below. General formula (1) showing the pyrazolinone compound (1)
Figure 2009143850
(Wherein, R 1, R 2, R 3, R 4 and R 5 are each a hydrogen atom, .R 6 is 1 hydrogen atom or a carbon atoms of a halogen atom or a halogen atom which may be substituted methyl group 5 represents an alkyl group.)
In this case, when at least one of R 1 , R 2 , R 3 , R 4 and R 5 is a halogen atom or a methyl group substituted by a halogen atom, the halogen atom is a fluorine atom, a chlorine atom, a bromine atom or an iodine Can be an atom. The methyl group substituted with a halogen atom may be a monohalomethyl group such as a monofluoromethyl group or a monochloromethyl group, a dihalomethyl group such as a difluoromethyl group or a dichloromethyl group, or a trihalomethyl group. It may be a trihalomethyl group such as a fluoromethyl group or a trichloromethyl group. When R 6 is an alkyl group having 1 to 5 carbon atoms, examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group, an isobutyl group, Examples thereof include a tert-butyl group and an n-pentyl group.

酸ハロゲン化物(2)を示す一般式(2)

Figure 2009143850
(式中、Xは塩素原子又は臭素原子を表し、Yは酸素原子又は硫黄原子を表す。R7は炭素数1〜5のアルキル基、炭素数3〜5のアルケニル基又は炭素数3〜5のアルキニル基を表す。)
において、R7が炭素数1〜5のアルキル基である場合、このアルキル基としては、例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、sec−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基等が挙げられる。R7が炭素数3〜5のアルケニル基である場合、このアルケニル基としては、例えば、アリル基(2−プロペニル基)、メタリル基(2−メチル−2−プロペニル基)、クロチル基(2−ブテニル基)等が挙げられる。R7が炭素数3〜5のアルキニル基である場合、このアルキニル基としては、例えば、2−プロピニル基、2−ブチニル基又は3−ブチニル基等が挙げられる。 General formula (2) showing acid halide (2)
Figure 2009143850
(Wherein, X represents a chlorine atom or a bromine atom, Y is .R 7 is an alkyl group having 1 to 5 carbon atoms, 3-5 alkenyl group carbon atoms or 3 to 5 carbon atoms an oxygen atom or a sulfur atom Represents an alkynyl group of
When R 7 is an alkyl group having 1 to 5 carbon atoms, examples of the alkyl group include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group, and an isobutyl group. Group, tert-butyl group, n-pentyl group and the like. When R 7 is an alkenyl group having 3 to 5 carbon atoms, examples of the alkenyl group include an allyl group (2-propenyl group), a methallyl group (2-methyl-2-propenyl group), a crotyl group (2- Butenyl group) and the like. When R 7 is an alkynyl group having 3 to 5 carbon atoms, examples of the alkynyl group include a 2-propynyl group, a 2-butynyl group, and a 3-butynyl group.

ピラゾリノン化合物(1)と酸ハロゲン化物(2)との反応は、塩基存在下で行われる。塩基としては、例えば、水酸化リチウム、水酸化ナトリウム、水酸化カリウムのようなアルカリ金属水酸化物、水酸化マグネシウム、水酸化カルシウムのようなアルカリ土類金属水酸化物、炭酸ナトリウム、炭酸カリウムのようなアルカリ金属炭酸塩、炭酸水素ナトリウム、炭酸水素カリウムのようなアルカリ金属重炭酸塩等の無機塩基や、ピリジン、4−(ジメチルアミノ)ピリジン、トリエチルアミン等の有機塩基が挙げられる。上記無機塩基を使用する場合、水溶液として使用することもできる。好ましくはアルカリ金属水酸化物の水溶液を用いる。 The reaction between the pyrazolinone compound (1) and the acid halide (2) is carried out in the presence of a base. Examples of the base include alkali metal hydroxides such as lithium hydroxide, sodium hydroxide and potassium hydroxide, alkaline earth metal hydroxides such as magnesium hydroxide and calcium hydroxide, sodium carbonate and potassium carbonate. Examples thereof include inorganic bases such as alkali metal carbonates, alkali metal bicarbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate, and organic bases such as pyridine, 4- (dimethylamino) pyridine and triethylamine. When using the said inorganic base, it can also be used as aqueous solution. Preferably, an aqueous solution of an alkali metal hydroxide is used.

反応に用いる酸ハロゲン化物(2)の使用量は、ピラゾリノン化合物(1)1モルに対して、通常0.5〜5モルであり、好ましくは0.9〜1.5モルである。反応に用いる塩基の使用量は、ピラゾリノン化合物(1)1モルに対し、通常1〜5モルであり、好ましくは1.5〜2.5モルである。 The usage-amount of the acid halide (2) used for reaction is 0.5-5 mol normally with respect to 1 mol of pyrazolinone compounds (1), Preferably it is 0.9-1.5 mol. The usage-amount of the base used for reaction is 1-5 mol normally with respect to 1 mol of pyrazolinone compounds (1), Preferably it is 1.5-2.5 mol.

反応は、塩基存在下、ピラゾリノン化合物(1)と酸ハロゲン化物(2)を水と有機溶媒の混合液中で行う。 In the reaction, the pyrazolinone compound (1) and the acid halide (2) are carried out in a mixture of water and an organic solvent in the presence of a base.

疎水性有機溶媒としては、例えば、ベンゼン、トルエン、キシレン、クロロベンゼンのような芳香族炭化水素、n−へキサン、n−へプタンのような脂肪族炭化水素、シクロペンタン、シクロヘキサンのような脂環式炭化水素、メチルエチルケトン、メチルイソブチルケトンのようなケトン、ジエチルエーテル、ジブチルエーテル、テトラヒドロフラン、テトラヒドロピランのようなエーテルなどが挙げられ、これらはそれぞれ単独で、または2種以上を組合せて用いることができる。 Examples of the hydrophobic organic solvent include aromatic hydrocarbons such as benzene, toluene, xylene and chlorobenzene, aliphatic hydrocarbons such as n-hexane and n-heptane, and alicyclic rings such as cyclopentane and cyclohexane. And hydrocarbons such as formula hydrocarbons, ketones such as methyl ethyl ketone and methyl isobutyl ketone, ethers such as diethyl ether, dibutyl ether, tetrahydrofuran and tetrahydropyran, and these can be used alone or in combination of two or more. .

疎水性有機溶媒と同時に、メタノール、エタノール、プロパノールのようなアルコール等の親水性有機溶媒を使用することもできる。 Simultaneously with the hydrophobic organic solvent, a hydrophilic organic solvent such as alcohol such as methanol, ethanol and propanol can be used.

水と疎水性有機溶媒は、予め反応器に添加しておいてもよいし、それぞれピラゾリノン化合物(1)または酸ハロゲン化物(2)と混合して添加してもよい。 Water and the hydrophobic organic solvent may be added to the reactor in advance, or may be added in combination with the pyrazolinone compound (1) or the acid halide (2).

上記の水、疎水性有機溶媒および親水性有機溶媒の合計使用量は、ピラゾリノン化合物(1)1重量部に対し、通常1〜20重量部であり、好ましくは1〜10重量部である。 The total amount of the water, the hydrophobic organic solvent and the hydrophilic organic solvent is usually 1 to 20 parts by weight, preferably 1 to 10 parts by weight with respect to 1 part by weight of the pyrazolinone compound (1).

反応温度は通常0〜100℃、好ましくは10〜50℃である。また、反応は、通常、常圧付近で行われるが、必要により加圧下又は減圧下で行われてもよい。反応方式としては、連続式、半連続式、回分式のいずれも採用することができる。 The reaction temperature is usually 0 to 100 ° C., preferably 10 to 50 ° C. In addition, the reaction is usually performed near normal pressure, but may be performed under pressure or under reduced pressure as necessary. As the reaction system, any of a continuous system, a semi-continuous system, and a batch system can be employed.

反応中のpHは通常10以上であり、通常は塩基あるいは塩酸などの酸を添加することにより調整する。 The pH during the reaction is usually 10 or more, and it is usually adjusted by adding a base or an acid such as hydrochloric acid.

仕込み順序には特に制限はなく、ピラゾリノン化合物(1)と塩基との混合物に酸ハロゲン化物(2)を加えてもよく、酸ハロゲン化物(2)にピラゾリノン化合物(1)と塩基との混合物を加えてもよい。 The order of preparation is not particularly limited, and the acid halide (2) may be added to the mixture of the pyrazolinone compound (1) and the base, and the mixture of the pyrazolinone compound (1) and the base may be added to the acid halide (2). May be added.

反応終了後の反応混合物を油水分離し、水層に酸を加えて中和し、目的物である一般式(3)

Figure 2009143850
(式中、R1、R2、R3、R4、R5、R6、R7及びYはそれぞれ前記と同じ意味を表す。)
で示されるピラゾリノン誘導体(3)を固体として析出させ、分離する。 After completion of the reaction, the reaction mixture is separated into oil and water, neutralized by adding an acid to the aqueous layer, and the target compound of the general formula (3)
Figure 2009143850
(Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and Y have the same meanings as described above).
Is precipitated as a solid and separated.

水層に加える酸としては、例えば、塩化水素や硫酸等が挙げられ、その水溶液が好ましく用いられる。酸の使用量は、ピラゾリノン化合物(1)1モルに対し、通常0.5〜5モルであり、好ましくは0.7〜1.5モルである。品質面、操作面から酸を加えた後の水層のpHは5以上であることが好ましく、また、ピラゾリノン誘導体(3)を十分に析出させるため、酸を加えた後の水層のpHは9以下であることが好ましい。pHの調整は、酸の使用量を調整することで行うことができる。 Examples of the acid added to the aqueous layer include hydrogen chloride and sulfuric acid, and an aqueous solution thereof is preferably used. The usage-amount of an acid is 0.5-5 mol normally with respect to 1 mol of pyrazolinone compounds (1), Preferably it is 0.7-1.5 mol. The pH of the aqueous layer after addition of the acid is preferably 5 or more from the aspect of quality and operation, and the pH of the aqueous layer after addition of the acid is sufficient to precipitate the pyrazolinone derivative (3) sufficiently. It is preferably 9 or less. The pH can be adjusted by adjusting the amount of acid used.

また、酸を加える前の水層は、ピラゾリノン誘導体(3)が溶解した状態であるのが好ましい。 Moreover, it is preferable that the aqueous layer before adding an acid is a state in which the pyrazolinone derivative (3) is dissolved.

水層に酸を加える時間は、析出するピラゾリノン誘導体(3)への前記副生物の取り込みを抑えるため、3時間以上とする。一方、上限は特に限定されないが、生産性の観点から通常20時間以下である。 The time for adding the acid to the aqueous layer is 3 hours or more in order to suppress the incorporation of the by-product into the precipitated pyrazolinone derivative (3). On the other hand, the upper limit is not particularly limited, but is usually 20 hours or less from the viewpoint of productivity.

酸を加え、ピラゾリノン誘導体(3)を析出させた後、該析出物を含む水層をろ過などの公知の分離手段によってピラゾリノン誘導体(3)を分離する。分離した析出物を水や有機溶媒によって洗浄することにより、目的物であるピラゾリノン誘導体(3)を固体として得ることができる。 After adding an acid to precipitate the pyrazolinone derivative (3), the aqueous layer containing the precipitate is separated from the pyrazolinone derivative (3) by a known separation means such as filtration. By washing the separated precipitate with water or an organic solvent, the target pyrazolinone derivative (3) can be obtained as a solid.

かくして、ピラゾリノン誘導体(3)を、収率良く、前記副生物の取り込みを抑制し、良好な品質で得ることができる。更に、必要に応じて、再結晶やカラムクロマトグラフィー等の手段により精製することも可能である。 Thus, the pyrazolinone derivative (3) can be obtained with good quality, in good yield, with reduced uptake of the by-product. Furthermore, it can be purified by means such as recrystallization or column chromatography, if necessary.

以下、本発明の実施例を示すが、本発明はこれによって限定されるものではない。 Examples of the present invention will be described below, but the present invention is not limited thereto.

実施例1
還流冷却器、温度計、攪拌器、滴下ロートを備えたガラス製反応器に、3−アミノ−4−(2−メチルフェニル)−ピラゾリン−5−オン〔一般式(1)においてR1がメチル基、R2、R3、R4、R5及びR6が水素原子である化合物〕45.00g(0.238モル)、メタノール45.00g、水16.16g、キシレン45.00g及び25%水酸化ナトリウム水溶液39.96gを入れ攪拌した。この水溶液に10%塩酸を加えてpHを約12.0に調整し、15℃にてアリルクロロチオホルメート〔一般式(2)においてXが塩素原子、Yが硫黄原子、R7がアリル基である化合物〕34.44g(0.252モル)とキシレン29.52gの混合溶液を2時間かけて滴下し、滴下終了後、同温度でさらに2時間攪拌した。アリルクロロチオホルメートの滴下及びその後の保温中、10%水酸化ナトリウム溶液を併注して反応系内のpHを約10.7に保った。その後、反応混合物を30分間静置して油水分離し、水層に25℃にて10%塩酸82.34gを3時間かけて滴下し、1−〔(2−プロペニルチオ)カルボニル〕−4−(2−メチルフェニル)−5−アミノ−1H−ピラゾール−3−オン〔一般式(3)においてR1がメチル基、R1、R2、R3、R4、R5及びR6が水素原子、Yが硫黄原子、R7がアリル基である化合物〕を析出させた。このときのpHは6.5であった。この析出物を含む水層をろ過した。ろ上物をn−へキサン、次いでメタノール水で洗浄し、1−〔(2−プロペニルチオ)カルボニル〕−4−(2−メチルフェニル)−5−アミノ−1H−ピラゾール−3−オンを58.61g得た。これを高速液体クロマトグラフィーにより分析し、純度を絶対検量線法により算出し、原料である3−アミノ−4−(2−メチルフェニル)−ピラゾリン−5−オンに対する収率を求めた。その結果、純度95.9%、収率85.2%であった。また、副生物である尿素化合物の含有量を面積百分率法にて算出したところ、その含有量は1.1%であった。
Example 1
A glass reactor equipped with a reflux condenser, a thermometer, a stirrer, and a dropping funnel was charged with 3-amino-4- (2-methylphenyl) -pyrazolin-5-one [in the general formula (1), R 1 represents methyl Group, R 2 , R 3 , R 4 , R 5 and R 6 are hydrogen atoms] 45.00 g (0.238 mol), methanol 45.00 g, water 16.16 g, xylene 45.00 g and 25% Sodium hydroxide aqueous solution 39.96g was put and stirred. 10% hydrochloric acid is added to this aqueous solution to adjust the pH to about 12.0, and at 15 ° C. allyl chlorothioformate [in the general formula (2), X is a chlorine atom, Y is a sulfur atom, R 7 is an allyl group. A mixed solution of 34.44 g (0.252 mol) and xylene 29.52 g was added dropwise over 2 hours, and after completion of the addition, the mixture was further stirred at the same temperature for 2 hours. During the dropwise addition of allyl chlorothioformate and subsequent warming, a 10% sodium hydroxide solution was added together to maintain the pH in the reaction system at about 10.7. Thereafter, the reaction mixture was allowed to stand for 30 minutes to separate oil and water, and 82.34 g of 10% hydrochloric acid was added dropwise to the aqueous layer at 25 ° C. over 3 hours to give 1-[(2-propenylthio) carbonyl] -4- (2-Methylphenyl) -5-amino-1H-pyrazol-3-one [in the general formula (3), R 1 is a methyl group, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are hydrogen] A compound in which an atom, Y is a sulfur atom, and R 7 is an allyl group] was deposited. The pH at this time was 6.5. The aqueous layer containing this precipitate was filtered. The filtered product was washed with n-hexane and then with methanolic water to give 1-[(2-propenylthio) carbonyl] -4- (2-methylphenyl) -5-amino-1H-pyrazol-3-one. Obtained .61 g. This was analyzed by high performance liquid chromatography, the purity was calculated by an absolute calibration curve method, and the yield relative to the starting material 3-amino-4- (2-methylphenyl) -pyrazolin-5-one was determined. As a result, the purity was 95.9% and the yield was 85.2%. Moreover, when the content of the urea compound as a by-product was calculated by the area percentage method, the content was 1.1%.

比較例1
実施例1と同様の反応器に、3−アミノ−4−(2−メチルフェニル)−ピラゾリン−5−オン15.00g(0.079モル)、メタノール15.00g、水7.49g、キシレン15.00g及び25%水酸化ナトリウム水溶液13.32gを入れ攪拌した。この水溶液に10%塩酸を加えてpHを12.0に調整し、15℃にてアリルクロロチオホルメート〔一般式(2)においてXが塩素原子、Yが硫黄原子、R7がアリル基である化合物〕10.61g(0.078モル)とキシレン9.10gの混合溶液を2時間かけて滴下し、滴下終了後、同温度でさらに2時間攪拌した。アリルクロロチオホルメートの滴下及びその後の保温中、10%水酸化ナトリウム溶液を併注して反応系内のpHを約10.7に保った。その後、反応混合物に25℃にて10%塩酸28.57gを0.5時間かけて滴下し、1−〔(2−プロペニルチオ)カルボニル〕−4−(2−メチルフェニル)−5−アミノ−1H−ピラゾール−3−オンを析出させた。このときのpHは6.5であった。これにn−へキサン30.00gを加え1時間攪拌後、ろ過した。ろ上物をn−へキサン、次いでメタノール水で洗浄し、1−〔(2−プロペニルチオ)カルボニル〕−4−(2−メチルフェニル)−5−アミノ−1H−ピラゾール−3−オンを19.28g得た。実施例1と同様に分析したところ、純度95.3%、収率85.9%であった。上記尿素化合物の含有量は1.8%であった。
Comparative Example 1
In the same reactor as in Example 1, 15.00 g (0.079 mol) of 3-amino-4- (2-methylphenyl) -pyrazolin-5-one, 15.00 g of methanol, 7.49 g of water, xylene 15 0.000 g and 25% aqueous sodium hydroxide solution 13.32 g were added and stirred. 10% hydrochloric acid was added to this aqueous solution to adjust the pH to 12.0, and at 15 ° C. allyl chlorothioformate [in general formula (2), X is a chlorine atom, Y is a sulfur atom, R 7 is an allyl group. A certain compound] A mixed solution of 10.61 g (0.078 mol) and 9.10 g of xylene was added dropwise over 2 hours. After completion of the addition, the mixture was further stirred at the same temperature for 2 hours. During the dropwise addition of allyl chlorothioformate and subsequent warming, a 10% sodium hydroxide solution was added together to maintain the pH in the reaction system at about 10.7. Thereafter, 28.57 g of 10% hydrochloric acid was added dropwise to the reaction mixture at 0.5 ° C. over 0.5 hour, and 1-[(2-propenylthio) carbonyl] -4- (2-methylphenyl) -5-amino- 1H-pyrazol-3-one was precipitated. The pH at this time was 6.5. To this was added 30.00 g of n-hexane, and the mixture was stirred for 1 hour and filtered. The filtered product was washed with n-hexane and then with aqueous methanol, and 1-[(2-propenylthio) carbonyl] -4- (2-methylphenyl) -5-amino-1H-pyrazol-3-one was converted to 19 .28 g was obtained. When analyzed in the same manner as in Example 1, the purity was 95.3% and the yield was 85.9%. The urea compound content was 1.8%.

Claims (3)

一般式(1)
Figure 2009143850
(式中、R1、R2、R3、R4及びR5はそれぞれ水素原子、ハロゲン原子又はハロゲン原子で置換されていてもよいメチル基を表す。R6は水素原子又は炭素数1〜5のアルキル基を表す。)で示されるピラゾリノン化合物と一般式(2)
Figure 2009143850
(式中、Xは塩素原子又は臭素原子を表し、Yは酸素原子又は硫黄原子を表す。R7は炭素数1〜5のアルキル基、炭素数3〜5のアルケニル基又は炭素数3〜5のアルキニル基を表す。)で示される酸ハロゲン化物を塩基存在下、水と疎水性有機溶媒との混合液中で反応させ、得られた反応混合物を油水分離し、水層に酸を加えて中和することにより一般式(3)
Figure 2009143850
(式中、R1、R2、R3、R4、R5、R6、R7及びYはそれぞれ前記と同じ意味を表す。)で示されるピラゾリノン誘導体を析出させ、分離することを特徴とするピラゾリノン誘導体の製造法。
General formula (1)
Figure 2009143850
(Wherein, R 1, R 2, R 3, R 4 and R 5 are each a hydrogen atom, .R 6 is 1 hydrogen atom or a carbon atoms of a halogen atom or a halogen atom which may be substituted methyl group And a pyrazolinone compound represented by the general formula (2):
Figure 2009143850
(In the formula, X represents a chlorine atom or a bromine atom, Y represents an oxygen atom or a sulfur atom. R 7 represents an alkyl group having 1 to 5 carbon atoms, an alkenyl group having 3 to 5 carbon atoms, or 3 to 5 carbon atoms. In the presence of a base in a mixed solution of water and a hydrophobic organic solvent, the resulting reaction mixture is separated into oil and water, and an acid is added to the aqueous layer. General formula (3) by neutralization
Figure 2009143850
(Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and Y each have the same meaning as described above) are precipitated and separated. And a method for producing a pyrazolinone derivative.
疎水性有機溶媒がトルエンおよび/またはキシレンであることを特徴とする請求項1に記載の製造法。 The production method according to claim 1, wherein the hydrophobic organic solvent is toluene and / or xylene. 一般式(1)で示されるピラゾリノン化合物が3−アミノ−4−(2−メチルフェニル)−ピラゾリン−5−オン、一般式(2)で示される酸ハロゲン化物がアリルクロロチオホルメートであり、生成物である一般式(3)で示されるピラゾリノン誘導体が1−〔(2−プロペニルチオ)カルボニル〕−4−(2−メチルフェニル)−5−アミノ−1H−ピラゾール−3−オンであることを特徴とする請求項1に記載の製造法。 The pyrazolinone compound represented by the general formula (1) is 3-amino-4- (2-methylphenyl) -pyrazolin-5-one, and the acid halide represented by the general formula (2) is allyl chlorothioformate, The product pyrazolinone derivative represented by the general formula (3) is 1-[(2-propenylthio) carbonyl] -4- (2-methylphenyl) -5-amino-1H-pyrazol-3-one The manufacturing method of Claim 1 characterized by these.
JP2007323130A 2007-12-14 2007-12-14 Method of preparing pyrazolinone derivative Withdrawn JP2009143850A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2007323130A JP2009143850A (en) 2007-12-14 2007-12-14 Method of preparing pyrazolinone derivative
CN2008801208809A CN101896466A (en) 2007-12-14 2008-12-12 Process for production of pyrazolinone derivative
PCT/JP2008/073140 WO2009078475A1 (en) 2007-12-14 2008-12-12 Process for production of pyrazolinone derivative
IL206085A IL206085A0 (en) 2007-12-14 2010-05-31 Process for producing of pyrazolinone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007323130A JP2009143850A (en) 2007-12-14 2007-12-14 Method of preparing pyrazolinone derivative

Publications (1)

Publication Number Publication Date
JP2009143850A true JP2009143850A (en) 2009-07-02

Family

ID=40795586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007323130A Withdrawn JP2009143850A (en) 2007-12-14 2007-12-14 Method of preparing pyrazolinone derivative

Country Status (4)

Country Link
JP (1) JP2009143850A (en)
CN (1) CN101896466A (en)
IL (1) IL206085A0 (en)
WO (1) WO2009078475A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009298709A (en) * 2008-06-11 2009-12-24 Sumitomo Chemical Co Ltd Method of preparing pyrazolinone derivative

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848517B (en) * 2019-04-30 2023-04-07 上海医药工业研究院 Preparation method of edaravone

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283209A (en) * 1995-04-11 1996-10-29 Sumitomo Chem Co Ltd Production of allylamine
JPH08295654A (en) * 1995-04-27 1996-11-12 Sumitomo Chem Co Ltd Purification of aniline
JP2005239603A (en) * 2004-02-25 2005-09-08 Sumitomo Chemical Co Ltd Method for producing 2-imidazolidinones
JP2007302619A (en) * 2006-05-12 2007-11-22 Sumitomo Chemical Co Ltd Method for producing pyrazolinone derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4395912B2 (en) * 1998-04-23 2010-01-13 住友化学株式会社 Pyrazolinone derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283209A (en) * 1995-04-11 1996-10-29 Sumitomo Chem Co Ltd Production of allylamine
JPH08295654A (en) * 1995-04-27 1996-11-12 Sumitomo Chem Co Ltd Purification of aniline
JP2005239603A (en) * 2004-02-25 2005-09-08 Sumitomo Chemical Co Ltd Method for producing 2-imidazolidinones
JP2007302619A (en) * 2006-05-12 2007-11-22 Sumitomo Chemical Co Ltd Method for producing pyrazolinone derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009298709A (en) * 2008-06-11 2009-12-24 Sumitomo Chemical Co Ltd Method of preparing pyrazolinone derivative

Also Published As

Publication number Publication date
IL206085A0 (en) 2010-11-30
CN101896466A (en) 2010-11-24
WO2009078475A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
JP4114754B2 (en) Process for producing 1-substituted-3-fluoroalkylpyrazole-4-carboxylic acid ester
JP2007326784A (en) Method for producing 1-substituted-5-fluoroalkylpyrazole-4-carboxylic acid ester
TW201429924A (en) Production method of refined amine compound
KR101653025B1 (en) Method for producing 2-amino-4-(trifluoromethyl)pyridine
HUE032621T2 (en) Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine
US8039680B2 (en) Process for producing 4-methyl-2,3,5,6-tetrafluorobenzyl alcohol
JP4862481B2 (en) Method for producing pyrazolinone derivatives
JP5181609B2 (en) Method for producing pyrazolinone derivative
JP2009143850A (en) Method of preparing pyrazolinone derivative
JP2007332129A (en) Method of manufacturing optically active 4-amino-3-substituted phenylbutanoic acid
JP6459852B2 (en) Method for producing ether compound
JP5139104B2 (en) Method for producing dibenzooxepin compound
WO2019170521A1 (en) Synthesis of obeticholic acid and synthesis intermediate
WO2018180943A1 (en) Method for producing halogen-containing pyrazol carboxylic acid and intermediate thereof
CN111511712B (en) Improved synthesis of monochloroacetophenone
KR101471047B1 (en) Improved process for preparation of highly pure bosentan
JP2009298709A (en) Method of preparing pyrazolinone derivative
US9650337B2 (en) Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate
JP2018024643A (en) Method for producing intermediate of biotin, and method for producing biotin
JP2008007503A (en) Method for producing 4-methylpyrazole-5-carboxylic ester
JP2004231521A (en) Method for synthesizing 3-chloro-5-nitrotoluene
WO2011049155A1 (en) Process for production of quinuclidine compounds
JP4896476B2 (en) Methyloxymethylaminopyridine derivative and method for producing the same
JP4018816B2 (en) Cycloheptenone derivative and method for producing the same, and method for producing cycloheptimidazole derivative using the same
JP2009067710A (en) Method for producing n-methacryloyl-4-cyano-3-trifluoromethylaniline

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130212

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130611

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130619

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130705

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20140311